Combining topical tretinoin (Retin-A) with minoxidil is one of the older dermatology practices in androgenetic alopecia treatment, dating to the 1990s. The combination has multiple proposed mechanisms: tretinoin enhances skin barrier permeability, improving minoxidil penetration; tretinoin may upregulate sulfotransferase (SULT1A1) expression in scalp tissue, increasing minoxidil activation; and tretinoin has independent effects on follicle differentiation that may benefit hair growth modestly.

The clinical evidence is moderately supportive. The classic 1986 Bazzano study showed tretinoin alone produced regrowth in some patients; subsequent combination studies showed tretinoin plus minoxidil outperformed minoxidil alone in most comparisons. Effect sizes are modest, typically 15–25% additional improvement over minoxidil alone in head-to-head trials. The technique appears to be particularly useful for minoxidil non-responders or partial responders, where SULT1A1 upregulation may convert non-responders to responders.

Practical use: typical protocol involves applying tretinoin 0.025–0.05% nightly or every other night, then continuing with minoxidil twice daily. Skin irritation is the major limiting factor, tretinoin causes peeling, redness, and increased sun sensitivity that can be disruptive. Starting at low concentration with gradual buildup helps tolerability. For patients seeking enhanced minoxidil response, this is a low-cost addition with reasonable supporting evidence. The combination should be discussed with prescribing dermatologists rather than self-implemented because of tolerability and combination management nuances.